Status:
UNKNOWN
Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia
Lead Sponsor:
General and Teaching Hospital Celje
Conditions:
Covid-19
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
In the current situation it is of great importance to discover a safe, cost-effective and available treatment strategy in order to limit the rapidly spreading SARS-Cov-2. Recent studies have shown tha...
Eligibility Criteria
Inclusion
- age \> 18 years,
- confirmed infection (positive PCR from nasopharyngeal swab),
- fullfilled hospital admission criteria
Exclusion
- pregnancy,
- known allergy for bromhexine or hydroxychloroquine,
- epilepsy,
- prolonged QTc interval,
- Child C liver disease,
- dementia,
- psychoorganic syndrome,
- terminal chronic disease
Key Trial Info
Start Date :
April 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04355026
Start Date
April 10 2020
End Date
July 31 2020
Last Update
April 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SB Celje
Celje, Slovenia, 3000